文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

消除南亚内脏利什曼病：前路漫漫。

Eliminating visceral leishmaniasis in South Asia: the road ahead.

机构信息

Drugs for Neglected Diseases Initiative, New Delhi, India

Benaras Hindu University, Varanasi, India.

出版信息

BMJ. 2019 Jan 22;364:k5224. doi: 10.1136/bmj.k5224.

DOI:10.1136/bmj.k5224
PMID:30670453
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6340338/
Abstract

highlight lessons from a regional collaboration to eliminate visceral leishmaniasis and identify priorities for the post-elimination plan

摘要

突出区域性合作消除内脏利什曼病的经验教训，并确定消除后计划的优先事项

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e055/6340338/7dbea0f45a20/rijs45502.f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e055/6340338/ea3834c5036c/rijs45502.f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e055/6340338/7dbea0f45a20/rijs45502.f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e055/6340338/ea3834c5036c/rijs45502.f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e055/6340338/7dbea0f45a20/rijs45502.f2.jpg

相似文献

[1]
Eliminating visceral leishmaniasis in South Asia: the road ahead.

BMJ. 2019-1-22

[2]
Treatment of visceral leishmaniasis in 2010: direction from Bihar State, India.

Future Microbiol. 2010-9

[3]
Drug combinations for visceral leishmaniasis.

Curr Opin Infect Dis. 2010-12

[4]
Comment on: leishmaniasis: an update of current pharmacotherapy.

Expert Opin Pharmacother. 2013-6

[5]
Progress in the treatment of a neglected infectious disease: visceral leishmaniasis.

Expert Rev Anti Infect Ther. 2004-4

[6]
An overview of visceral leishmaniasis elimination program in India: a picture imperfect.

Expert Rev Anti Infect Ther. 2014-8

[7]
Challenges in the management of visceral leishmaniasis.

Indian Pediatr. 2005-6

[8]
Elimination of visceral leishmaniasis on the Indian subcontinent.

Lancet Infect Dis. 2016-12

[9]
Elimination of Kala-Azar from the Southeast Asia Region.

Am J Trop Med Hyg. 2017-4

[10]
Leishmaniasis: an update of current pharmacotherapy.

Expert Opin Pharmacother. 2012-12-21

引用本文的文献

[1]
Unravelling drug resistance in leishmaniasis: genomic adaptations and emerging therapies.

Front Mol Biosci. 2025-5-26

[2]
Exploring real-time PCR techniques for diagnosing leishmaniasis: key insights from a systematic review.

Parasitol Res. 2025-5-21

[3]
Advances and Challenges in the Diagnosis of Leishmaniasis.

Mol Diagn Ther. 2025-3

[4]
Dogs as Reservoirs for Leishmania donovani, Bihar, India, 2018-2022.

Emerg Infect Dis. 2024-12

[5]
Leishmaniasis in Humans and Animals: A One Health Approach for Surveillance, Prevention and Control in a Changing World.

Trop Med Infect Dis. 2024-10-28

[6]
Impact of climate and land use on the temporal variability of sand fly density in Sri Lanka: A 2-year longitudinal study.

PLoS Negl Trop Dis. 2024-11-21

[7]
Barriers and facilitators of visceral leishmaniasis case management in the Amhara Region, Northwest Ethiopia: an exploratory qualitative study.

BMC Public Health. 2024-9-13

[8]
Is Leishmaniasis donovani elimination feasible in Bhutan? A review of current prevention and control mechanisms in Bhutan.

Bhutan Health J. 2020-11

[9]
Occupational exposure to malaria, leishmaniasis and arbovirus vectors in endemic regions: A systematic review.

Curr Res Parasitol Vector Borne Dis. 2024-6-1

[10]
Design, Conduct, Analysis, and Reporting of Therapeutic Efficacy Studies in Visceral Leishmaniasis: A Systematic Review of Published Reports, 2000-2021.

Am J Trop Med Hyg. 2024-8-7

本文引用的文献

[1]
Quantifying the Infectiousness of Post-Kala-Azar Dermal Leishmaniasis Toward Sand Flies.

Clin Infect Dis. 2019-7-2

[2]
Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and Perspectives.

Clin Microbiol Rev. 2018-8-29

[3]
Policy Recommendations From Transmission Modeling for the Elimination of Visceral Leishmaniasis in the Indian Subcontinent.

Clin Infect Dis. 2018-6-1

[4]
New insights into leishmaniasis in the immunosuppressed.

PLoS Negl Trop Dis. 2018-5-10

[5]
Development and Evaluation of a Novel Loop-Mediated Isothermal Amplification Assay for Diagnosis of Cutaneous and Visceral Leishmaniasis.

J Clin Microbiol. 2018-6-25

[6]
Bionomics of Phlebotomus argentipes in villages in Bihar, India with insights into efficacy of IRS-based control measures.

PLoS Negl Trop Dis. 2018-1-11

[7]
A Combined Syndromic Approach to Examine Viral, Bacterial, and Parasitic Agents among Febrile Patients: A Pilot Study in Kilombero, Tanzania.

Am J Trop Med Hyg. 2017-12-21

[8]
Post-kala-azar dermal leishmaniasis in the Indian subcontinent: A threat to the South-East Asia Region Kala-azar Elimination Programme.

PLoS Negl Trop Dis. 2017-11-16

[9]
Towards elimination of visceral leishmaniasis in the Indian subcontinent-Translating research to practice to public health.

PLoS Negl Trop Dis. 2017-10-12

[10]
Control of Phlebotomus argentipes (Diptera: Psychodidae) sand fly in Bangladesh: A cluster randomized controlled trial.

PLoS Negl Trop Dis. 2017-9-5

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索